Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
NHS Framework for the NHS North of England Region, Branded Medicines - Tranche B, Cytokine Modulators and other monoclonal Antibodies, and Fondaparinux
Offer reference number: CM/PHR/16/5527
CM/PHR/16/5527/01: NHS Framework for the NHS North Of England Region, Branded Medicines, Tranche B, 1 March 2020 to 28 February 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/16/5527/02: NHS Framework for the NHS North Of England Region, Branded Medicines Annual Tranche, Cytokine Modulators and other monoclonal antibodies, 1 March 2020 to 28 February 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/16/5527/03: NHS Framework agreement for Fondaparinux
London, 1 March 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
South of England, 1 March 2020 to 31 August 2020 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Midlands and East, 1 March 2020 to 28 February 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| ACRE PHARMA LIMITED | 08276151 | £205,535,556 | - |
| AMGEN LIMITED | 02354269 | £205,535,556 | - |
| ASPEN PHARMA LTD | 08752963 | £205,535,556 | - |
| ASTELLAS PHARMA LTD. | 00787610 | £205,535,556 | LOBBYIST Ovid Consulting Ltd (1 quarter) |
| BAYER PUBLIC LIMITED COMPANY | 00935048 | £205,535,556 | LOBBYIST Ovid Consulting Ltd (6 quarters) Hill & Knowlton Limited (2 quarters) Hanover Communications International Limited (1 quarter) iNHouse Communications Limited (1 quarter) |
| BIOGEN LTD | 06151086 | £205,535,556 | - |
| BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED | 02487574 | £205,535,556 | LOBBYIST Hanover Communications International Limited (4 quarters) DGA Group UK Limited (3 quarters) FTI Consulting LLP (3 quarters) Ovid Consulting Ltd (2 quarters) |
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED | 11685363 | £205,535,556 | - |
| DAIICHI SANKYO UK LIMITED | 01998736 | £205,535,556 | LOBBYIST WA Communications Ltd (2 quarters) Hanover Communications International Limited (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| DR. REDDY'S LABORATORIES (EU) LIMITED | 02177715 | £205,535,556 | - |
| ELI LILLY AND COMPANY LIMITED | 00284385 | £205,535,556 | DONOR£9K across 1 donation To: Conservative and Unionist Party LOBBYIST IPG DXTRA (UK) LIMITED (1 quarter) |
| FERRING PHARMACEUTICALS LIMITED | 01198007 | £205,535,556 | DONOR£1.44M across 11 donations To: Liberal Democrats |
| GEDEON RICHTER (UK) LIMITED | 04325685 | £205,535,556 | - |
| GILEAD SCIENCES LTD | 02543818 | £205,535,556 | LOBBYIST Ovid Consulting Ltd (4 quarters) Portland PR Limited (1 quarter) WA Communications Ltd (1 quarter) |
| IPSEN LIMITED | 06751069 | £205,535,556 | LOBBYIST Burkitt Communications Ltd (2 quarters) WA Communications Ltd (1 quarter) |
| JANSSEN-CILAG LIMITED | 01027904 | £205,535,556 | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| MERCK SERONO LIMITED | 00990823 | £205,535,556 | MP LINK Munira Wilson— Employment and earnings |
| MERCK SHARP & DOHME LIMITED | 00820771 | £205,535,556 | LOBBYIST Incisive Health Ltd (2 quarters) Hanover Communications International Limited (2 quarters) M&F Health (2 quarters) |
| MYLAN LIMITED | 05460854 | £205,535,556 | - |
| NAPP LABORATORIES LIMITED | 00192707 | £205,535,556 | - |
| NOVARTIS PHARMACEUTICALS UK LIMITED | 00119006 | £205,535,556 | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
| NOVO NORDISK LIMITED | 01118740 | £205,535,556 | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| PFIZER LIMITED | 00526209 | £205,535,556 | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| PHARMASURE LIMITED | 03929804 | £205,535,556 | - |
| PROFILE PHARMA LIMITED | 04005203 | £205,535,556 | - |
| ROCHE PRODUCTS LIMITED | 00100674 | £205,535,556 | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| ROVI BIOTECH LIMITED | 09339446 | £205,535,556 | - |
| SANDOZ LIMITED | 01547204 | £205,535,556 | - |
| SANOFI-AVENTIS UK HOLDINGS LIMITED | 03203829 | £205,535,556 | - |
| TAKEDA UK LIMITED | 03362860 | £205,535,556 | LOBBYIST Hill & Knowlton Limited (3 quarters) MHP Communications (2 quarters) Hanover Communications International Limited (2 quarters) Incisive Health Ltd (1 quarter) Burkitt Communications Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| TECHDOW PHARMA ENGLAND LIMITED | 10513412 | £205,535,556 | - |
| TEVA UK LIMITED | 00302461 | £205,535,556 | - |
| THERAMEX HQ UK LIMITED | 10944626 | £205,535,556 | - |
| TYPHARM LIMITED | 00894611 | £205,535,556 | - |
| UCB PHARMA LIMITED | 00209905 | £205,535,556 | - |
Government spending data: These suppliers have received £1,007,532,543 in 10,013 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, Manchester University NHS Foundation Trust, NHS England, Guy's and St Thomas' NHS FT and 20 more public bodies (2010-05-13 to 2026-03-31).